Worzner K, Schmidt S, Zimmermann J, Tami A, Polacek C, Fernandez-Antunez C
EBioMedicine. 2025; 113:105615.
PMID: 39983329
PMC: 11893338.
DOI: 10.1016/j.ebiom.2025.105615.
van Doremalen N, Avanzato V, Goldin K, Feldmann F, Schulz J, Haddock E
NPJ Vaccines. 2022; 7(1):171.
PMID: 36543806
PMC: 9768398.
DOI: 10.1038/s41541-022-00592-9.
Gholizadeh O, Yasamineh S, Amini P, Afkhami H, Delarampour A, Akbarzadeh S
Virol J. 2022; 19(1):206.
PMID: 36463213
PMC: 9719161.
DOI: 10.1186/s12985-022-01935-7.
Christensen D, Polacek C, Sheward D, Hanke L, Moliner-Morro A, McInerney G
EBioMedicine. 2022; 84:104248.
PMID: 36088218
PMC: 9448948.
DOI: 10.1016/j.ebiom.2022.104248.
Selvam S, Ramani P, R R, Sundar S, T A L
Cureus. 2022; 14(5):e24927.
PMID: 35706739
PMC: 9187843.
DOI: 10.7759/cureus.24927.
Development of COVID 19 vaccine: A summarized review on global trials, efficacy, and effectiveness on variants.
Prakash S
Diabetes Metab Syndr. 2022; 16(4):102482.
PMID: 35427915
PMC: 8990436.
DOI: 10.1016/j.dsx.2022.102482.
Infection with the SARS-CoV-2 B.1.351 variant is lethal in aged BALB/c mice.
Yasui F, Matsumoto Y, Yamamoto N, Sanada T, Honda T, Munakata T
Sci Rep. 2022; 12(1):4150.
PMID: 35264719
PMC: 8907250.
DOI: 10.1038/s41598-022-08104-4.
The Current Status of COVID-19 Vaccines.
Lundstrom K
Front Genome Ed. 2021; 2:579297.
PMID: 34713220
PMC: 8525400.
DOI: 10.3389/fgeed.2020.579297.
Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis.
Purkayastha P, Mckechnie C, Kalkur P, Scully M
BMJ Case Rep. 2021; 14(9).
PMID: 34556531
PMC: 8461674.
DOI: 10.1136/bcr-2021-245092.
Overview of Nonhuman Primate Models of SARS-CoV-2 Infection.
Trichel A
Comp Med. 2021; 71(5):411-432.
PMID: 34548126
PMC: 8594265.
DOI: 10.30802/AALAS-CM-20-000119.
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models.
Lambe T, Spencer A, Thomas K, Gooch K, Thomas S, White A
Commun Biol. 2021; 4(1):915.
PMID: 34312487
PMC: 8313674.
DOI: 10.1038/s42003-021-02443-0.
Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A review.
Goyal M, Tewatia N, Vashisht H, Jain R, Kumar S
J Infect Public Health. 2021; 14(7):910-921.
PMID: 34119845
PMC: 8088038.
DOI: 10.1016/j.jiph.2021.04.011.
Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19.
Bezbaruah R, Borah P, Kakoti B, Al-Shari N, Chandrasekaran B, Jaradat D
Front Mol Biosci. 2021; 8:635337.
PMID: 33937326
PMC: 8082173.
DOI: 10.3389/fmolb.2021.635337.
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents.
Rauch S, Roth N, Schwendt K, Fotin-Mleczek M, Mueller S, Petsch B
NPJ Vaccines. 2021; 6(1):57.
PMID: 33863911
PMC: 8052455.
DOI: 10.1038/s41541-021-00311-w.
Super-rapid race for saving lives by developing COVID-19 vaccines.
Uttarilli A, Amalakanti S, Kommoju P, Sharma S, Goyal P, Manjunath G
J Integr Bioinform. 2021; 18(1):27-43.
PMID: 33761582
PMC: 8035961.
DOI: 10.1515/jib-2021-0002.
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.
van der Lubbe J, Huber S, Vijayan A, Dekking L, van Huizen E, Vreugdenhil J
NPJ Vaccines. 2021; 6(1):39.
PMID: 33741993
PMC: 7979827.
DOI: 10.1038/s41541-021-00301-y.
Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review.
Sakr M, Elsayed N, El-Housseiny G
Microb Pathog. 2021; 154:104809.
PMID: 33647446
PMC: 7910145.
DOI: 10.1016/j.micpath.2021.104809.
Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects.
Arashkia A, Jalilvand S, Mohajel N, Afchangi A, Azadmanesh K, Salehi-Vaziri M
Rev Med Virol. 2021; 31(3):e2183.
PMID: 33594794
PMC: 7646037.
DOI: 10.1002/rmv.2183.
Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies.
Lopes-Pacheco M, Silva P, Cruz F, Battaglini D, Robba C, Pelosi P
Front Physiol. 2021; 12:593223.
PMID: 33584343
PMC: 7876335.
DOI: 10.3389/fphys.2021.593223.
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2.
Singh D, Han I, Choi E, Yadav D
Front Cell Dev Biol. 2020; 8:580202.
PMID: 33240881
PMC: 7677140.
DOI: 10.3389/fcell.2020.580202.
